Nadel: Forefront avoids biotech because it is capital-intensive and slow to revenue
Phil Nadel · 11 - Backing Extraordinary Founders with Founder and Managing Director of Forefront Venture Partners Phil Nadel · Dec 12, 2024 · at 3:10
Phil Nadel, Managing Director of Forefront Venture Partners, explains why his firm excludes biotech companies from its sector-agnostic mandate.
0:00 / 0:13exact quote · 13.9s
720p mp4 · rendered on demand · StarZero watermark
“We don't invest in any biotech because it's very research and development heavy. So there's a lot of capital expense there, and it takes a long time before you start to see some revenue. So not exactly the most capital efficient type of company.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Phil Nadel
Nadel rejects Silicon Valley's 'grow at all costs' mentality
“We do not believe in a grow at all costs. Mentality. That is just not our mentality at all, and I know that's contrary to a lot of investors in Silicon Valley and whatnot”
Nadel: Early-stage projections reveal founder thinking, not accurate numbers
“And then we spend a long time analyzing financial projections, and we do that knowing full well that the projections are never going to be accurate, and that's not what we're looking for. We're looking to get a peek Into the founding team's head to understand …”
Nadel: First-time founders often misunderstand LP return requirements during valuation asks
“Sometimes younger, newer founders, first time founders don't fully understand the dynamic around that. And Especially when they're trying to make a case for a higher valuation and that kind of thing. They're not fully understanding that there's a balance there…”
Nadel: Forefront only invests in revenue-generating Seed through Series B startups
“So Forefront invests in seed to Series B rounds in companies that are generating revenue. We have a relatively low revenue minimum, but we do have a minimum. So we're not looking at pre-revenue. We're not looking at pre-seed. It's gotta be seed to Series B and…”
Nadel: Pitch decks should solely aim to get a meeting
“The goal of the deck, the goal of that first outreach is to get a meeting. That's all. You're not going to get an investment after your first email to an investor, right? It's a process, and every step, you want to get that next step.”
Nadel: Many portfolio founders become Forefront LPs
“Many of the founders in our portfolio end up being LPs in our fund because they understand the level of due diligence that we do and the, how seriously we take our responsibility to our LPs and our focus on producing not only a diversified portfolio, but excel…”